| CAS NO. |
Products Name |
|
|
| 159138-80-4 |
CARIPORIDE |
more... |
| Acute Myocardial Infarction, Treatment of, CARDIOVASCULAR DRUGS, Coronary Bypass Surgery, Treatment of Disorders of the Coronary Arteries and Atherosclerosis, Na+/H+ Exchange type 1 (NHE-1) Inhibitors |
|
|
|
| 574013-66-4 |
Fexaramine |
more... |
| Fexaramine is a small molecule farnesoid X receptor (FXR) agonist with 100-fold increased affinity relative to natural compounds. |
|
| 1345847-93-9 |
Altiratinib(DCC-2701) |
more... |
| Altiratinib(DCC-2701) is a novel c-MET/TIE-2/VEGFR inhibitor; effectively reduce tumor burden in vivo and block c-MET pTyr(1349)-mediated signaling, cell growth and migration as compared with a HGF antagonist in vitro. |
|
|
|
|
|
| 223387-75-5 |
FG-2216 |
more... |
| FG-2216 is a potent HIF-prolyl hydroxylase inhibitor with IC50 of 3.9 uM for PDH2 enzyme; orally bioavailable and induced significant and reversible Epo induction in vivo. |
|
| 193551-21-2 |
SB 239063 |
more... |
| SB 239063 is a potent and selective p38 MAPK inhibitor (IC50 = 44 nM for p38α). SB 239063 displays > 220-fold selectivity over ERK, JNK1 and other kinases; ~ 3-fold more selective than SB 203580. |
|
|
|
| 304909-07-7 |
SANT-1 |
more... |
| SANT-1 directly binds to Smoothened (Smo) receptor with Kd of 1.2 nM and inhibits Smo agonist effects with IC50 of 20 nM |
|
| 183204-72-0 |
Tipiralacil |
more... |
| Tipiralacil, also known as TPI, is a thymidine phosphorylase inhibitor (TPI). Tipiracil is one of the active components in TAS-102, which is an anticancer drug candidate currently in clinical trials. |
|
All Products
